Study reviews the status of microbial succinic acid production

The current status and future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the peer-reviewed journal Industrial Biotechnology.

Succinic acid is one of the most important platform chemicals, with applications as a pharmaceutical ingredient, food additive, precursor of various chemicals, and raw material for biobased polymers. There is increasing demand for the sustainable production of succinic acid and its derivatives.

Sang Yup Lee, from the Korea Advanced Institute of Science and Technology (KAIST), and coauthors, review the status of microbial succinic acid production, summarizing the titer, yield, and productivity achieved by various metabolically engineered microorganisms. They also discuss downstream processes for the purification of biobased succinic acid and showcase microbial production of several succinic acid derivatives of interest.

This paper, submitted by Professor Sang Yup Lee, a highly distinguished innovator and pioneer in the field of systems metabolic engineering, is an excellent example of the cutting-edge science published by Industrial Biotechnology."

Richard A. Gross, PhD, Editor-in-Chief, Mary Ann Liebert, Inc.

Source:
Journal reference:

Kim, J. K., et al. (2023) Biobased Production of Succinic Acid and Its Derivatives Using Metabolically Engineered Microorganisms. Industrial Biotechnology.doi.org/10.1089/ind.2023.0001.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Squid-inspired technology could replace needles for medications and vaccines